Epidemiology, risk factors, prevention, and early detection of melanoma.
暂无分享,去创建一个
[1] Lawrence E Gibson,et al. Increasing incidence of melanoma among young adults: an epidemiological study in Olmsted County, Minnesota. , 2012, Mayo Clinic proceedings.
[2] Amy Y. Chen,et al. Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis. , 2008, The Lancet. Oncology.
[3] A. Halpern,et al. Patterns of detection in patients with cutaneous melanoma , 2000, Cancer.
[4] D. Rigel,et al. The Evolution of Melanoma Diagnosis: 25 Years Beyond the ABCDs , 2010, CA: a cancer journal for clinicians.
[5] B. Gilchrest,et al. The pathogenesis of melanoma induced by ultraviolet radiation. , 1999, The New England journal of medicine.
[6] W. O. Jones,et al. Incidence of Malignant Melanoma in Auckland, New Zealand: Highest Rates in the World , 1999, World Journal of Surgery.
[7] S. Swetter,et al. Factors related to the presentation of thin and thick nodular melanoma from a population‐based cancer registry in Queensland Australia , 2009, Cancer.
[8] Tim K. Lee,et al. Sun exposure and melanoma risk at different latitudes: a pooled analysis of 5700 cases and 7216 controls , 2009, International journal of epidemiology.
[9] U. P. S. T. Force,et al. Screening for skin cancer: U.S. Preventive Services Task Force recommendation statement. , 2009 .
[10] S. Gandini,et al. Reviews on sun exposure and artificial light and melanoma. , 2011, Progress in biophysics and molecular biology.
[11] C. Balch,et al. Melanoma in the Older Patient: Measuring Frailty as an Index of Survival , 2011, Annals of Surgical Oncology.
[12] H. Adami,et al. Obesity and risk of malignant melanoma: a meta-analysis of cohort and case-control studies. , 2013, European journal of cancer.
[13] Sabine Siesling,et al. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. , 2008, European journal of cancer.
[14] P. Boyle,et al. Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. , 2005, European journal of cancer.
[15] S. Swetter,et al. The expanding melanoma burden in California hispanics , 2011, Cancer.
[16] V. Moyer. Behavioral Counseling to Prevent Skin Cancer: U.S. Preventive Services Task Force Recommendation Statement , 2012, Annals of Internal Medicine.
[17] A. Qureshi,et al. Personal history of prostate cancer and increased risk of incident melanoma in the United States. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] N. Hayward,et al. Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. , 2003, Journal of the National Cancer Institute.
[19] Ian Jackson,et al. Variants of the melanocyte–stimulating hormone receptor gene are associated with red hair and fair skin in humans , 1995, Nature Genetics.
[20] Ivana K. Kim,et al. Germline BAP1 Inactivation Is Preferentially Associated with Metastatic Ocular Melanoma and Cutaneous-Ocular Melanoma Families , 2012, PloS one.
[21] Kari Stefansson,et al. ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma , 2008, Nature Genetics.
[22] Donald R. Miller,et al. Melanoma epidemic: an analysis of six decades of data from the Connecticut Tumor Registry. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] M. Weinstock,et al. Do tanning lamps cause melanoma? An epidemiologic assessment. , 1998, Journal of the American Academy of Dermatology.
[24] F. Sera,et al. Hormonal and reproductive factors in relation to melanoma in women: current review and meta-analysis. , 2011, European journal of cancer.
[25] Emily White,et al. A cohort study of vitamin D intake and melanoma risk. , 2009, The Journal of investigative dermatology.
[26] T. Fennell,et al. Melanoma genome sequencing reveals frequent PREX2 mutations , 2012, Nature.
[27] J. Aitken,et al. Trends for in situ and Invasive Melanoma in Queensland, Australia, 1982–2002 , 2006, Cancer Causes & Control.
[28] P. Boyle,et al. Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors. , 2005, European journal of cancer.
[29] S. Puig,et al. Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents , 2006, Journal of Medical Genetics.
[30] A. Halpern,et al. Reducing mortality in individuals at high risk for advanced melanoma through education and screening. , 2011, Journal of the American Academy of Dermatology.
[31] O. Gefeller,et al. Malignant Melanoma of the Skin: Long-term Follow-up and Time to First Recurrence , 2011, World Journal of Surgery.
[32] R. Stern,et al. Incidence of skin cancer in 5356 patients following organ transplantation , 2000, The British journal of dermatology.
[33] R. Liu,et al. Meta-analysis of the relationship between Parkinson disease and melanoma , 2011, Neurology.
[34] Myles G Cockburn,et al. Increasing burden of melanoma in the United States. , 2009, The Journal of investigative dermatology.
[35] M. Weinstock,et al. Does skin cancer screening save lives? , 2012, Cancer.
[36] B K Armstrong,et al. Epidemiology of malignant melanoma: intermittent or total accumulated exposure to the sun? , 1988, The Journal of dermatologic surgery and oncology.
[37] A. Halpern,et al. Cutaneous melanoma risk and phenotypic changes in large congenital nevi: a follow-up study of 46 patients. , 1998, Journal of the American Academy of Dermatology.
[38] H. Curtis. Biological mechanisms underlying the aging process. , 1963, Science.
[39] A. Kopf,et al. Early detection of malignant melanoma: The role of physician examination and self‐examination of the skin , 1985, CA: a cancer journal for clinicians.
[40] Jessica King,et al. Racial and ethnic variations in incidence and survival of cutaneous melanoma in the United States, 1999-2006. , 2011, Journal of the American Academy of Dermatology.
[41] D. Easton,et al. Lifetime risks of common cancers among retinoblastoma survivors. , 2004, Journal of the National Cancer Institute.
[42] A. Jemal,et al. Cancer statistics, 2014 , 2014, CA: a cancer journal for clinicians.
[43] J. Brewer,et al. Iatrogenic immunosuppression and cutaneous malignancy. , 2011, Clinics in dermatology.
[44] J. Fridlyand,et al. Distinct sets of genetic alterations in melanoma. , 2005, The New England journal of medicine.
[45] S. Swetter,et al. California Medicaid enrollment and melanoma stage at diagnosis: a population-based study. , 2008, American journal of preventive medicine.
[46] S. Swetter,et al. Melanoma underreporting: why does it happen, how big is the problem, and how do we fix it? , 2008, Journal of the American Academy of Dermatology.
[47] Manuel Serrano,et al. The common biology of cancer and ageing , 2007, Nature.
[48] Jacqueline Whetteckey,et al. Malignant melanoma and levodopa in Parkinson's disease: causality or coincidence? , 2003, Parkinsonism & related disorders.
[49] C. Balch,et al. Epidemiology and treatment of melanoma in elderly patients , 2010, Nature Reviews Clinical Oncology.
[50] A. Halpern,et al. Overcoming obstacles to skin cancer examinations and prevention counseling for high-risk patients: results of a national survey of primary care physicians. , 2004, The Journal of the American Board of Family Practice.
[51] Xianglin L. Du,et al. Ethnic differences among patients with cutaneous melanoma. , 2006, Archives of internal medicine.
[52] Sean Davis,et al. Interferon-γ links ultraviolet radiation to melanomagenesis in mice. , 2011, Nature.
[53] D. Jukic,et al. Pediatric melanoma: Analysis of an international registry , 2013, Cancer.
[54] A. Berghold,et al. Calcinosis cutis: part I. Diagnostic pathway. , 2011, Journal of the American Academy of Dermatology.
[55] G. Belch,et al. Promotion of frequent tanning sessions by indoor tanning facilities: two studies. , 2002, Journal of the American Academy of Dermatology.
[56] F. Sera,et al. Meta-analysis of risk factors for cutaneous melanoma according to anatomical site and clinico-pathological variant. , 2009, European journal of cancer.
[57] L. Bemis,et al. miR in melanoma development: miRNAs and acquired hallmarks of cancer in melanoma. , 2013, Physiological genomics.
[58] Gail M Williams,et al. Reduced melanoma after regular sunscreen use: randomized trial follow-up. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[59] N. Hayward,et al. Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma , 1996, Nature Genetics.
[60] D. Fisher,et al. Stemming the tanning bed epidemic: time for action. , 2012, Journal of the National Comprehensive Cancer Network : JNCCN.
[61] Jennifer S. Lin,et al. Behavioral Counseling to Prevent Skin Cancer: A Systematic Review for the U.S. Preventive Services Task Force , 2011, Annals of Internal Medicine.
[62] Boice Jd,et al. Second cancer following cutaneous melanoma and cancers of the brain, thyroid, connective tissue, bone, and eye in Connecticut, 1935-82. , 1985 .
[63] R. Scott,et al. Xeroderma pigmentosum genes and melanoma risk , 2013, International journal of cancer.
[64] Alan Geller,et al. Visual screening for malignant melanoma: a cost-effectiveness analysis. , 2007, Archives of dermatology.
[65] N Cascinelli,et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[66] Risk factors for cutaneous melanoma. A practical method of recognizing predisposed individuals. , 1987 .
[67] J. Belsky,et al. The health and development of children born to older mothers in the United Kingdom: observational study using longitudinal cohort data , 2012, BMJ : British Medical Journal.
[68] J. Fulton,et al. Reporting cutaneous melanoma to cancer registries in the United States. , 2003, Journal of the American Academy of Dermatology.
[69] J. Goodwin,et al. Socioeconomic Status and Survival in Older Patients with Melanoma , 2006, Journal of the American Geriatrics Society.
[70] D. English,et al. Clinical whole‐body skin examination reduces the incidence of thick melanomas , 2009, International journal of cancer.
[71] C. Balch,et al. Melanoma in children and teenagers: an analysis of patients from the National Cancer Data Base. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[72] David Polsky,et al. Early diagnosis of cutaneous melanoma: revisiting the ABCD criteria. , 2004, JAMA.
[73] C. Mathers,et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.
[74] P. Boyle,et al. Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. , 2005, European journal of cancer.
[75] G. Armstrong,et al. Melanoma as a subsequent neoplasm in adult survivors of childhood cancer: A report from the childhood cancer survivor study , 2013, Pediatric blood & cancer.
[76] F. Sera,et al. MC1R variants, melanoma and red hair color phenotype: A meta‐analysis , 2008, International journal of cancer.
[77] V. Sondak,et al. Age as a Prognostic Factor in Patients with Localized Melanoma and Regional Metastases , 2013, Annals of Surgical Oncology.
[78] D. Schadendorf,et al. Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma , 2014, Nature.
[79] A. Geller. Educational and screening campaigns to reduce deaths from melanoma. , 2009, Hematology/oncology clinics of North America.
[80] B. Meiser,et al. Skin cancer-related prevention and screening behaviors: a review of the literature , 2009, Journal of Behavioral Medicine.
[81] J. Kładny,et al. Common variants of DNA repair genes and malignant melanoma. , 2008, European journal of cancer.
[82] K. Freedberg,et al. Screening for malignant melanoma: A cost-effectiveness analysis. , 1999, Journal of the American Academy of Dermatology.
[83] C. la Vecchia,et al. Cancer risk in women with previous breast cancer. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.
[84] E. Chang,et al. Nonsteroidal anti‐inflammatory drugs and the risk of skin cancer , 2012, Cancer.
[85] A. Kopf,et al. RISK GRADIENT FOR MALIGNANT MELANOMA IN INDIVIDUALS WITH DYSPLASTIC NAEVI , 1988, The Lancet.
[86] B. Wood. Desmoplastic melanoma: recent advances and persisting challenges , 2013, Pathology.
[87] A. Swerdlow,et al. The risk of melanoma in patients with congenital nevi: a cohort study. , 1995, Journal of the American Academy of Dermatology.
[88] S. Gruber,et al. Is physician detection associated with thinner melanomas? , 1999, JAMA.
[89] F. Hodi,et al. Molecular genetics of familial cutaneous melanoma. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[90] P. Duray,et al. Neonatal sunburn and melanoma in mice , 2001, Nature.
[91] G. Ziegelberger,et al. International commission on non-ionizing radiation protection. , 2006, Progress in biophysics and molecular biology.
[92] Glenn Merlino,et al. Ultraviolet radiation and cutaneous malignant melanoma , 2003, Oncogene.
[93] Peter Boyle,et al. Cutaneous melanoma attributable to sunbed use: systematic review and meta-analysis , 2012, BMJ : British Medical Journal.
[94] J. Lortet-Tieulent,et al. International trends in the incidence of malignant melanoma 1953–2008—are recent generations at higher or lower risk? , 2013, International journal of cancer.
[95] Christopher F. Martin,et al. Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease. , 2012, Gastroenterology.
[96] Donald R. Miller,et al. The first 15 years of the American Academy of Dermatology skin cancer screening programs: 1985-1999. , 2003, Journal of the American Academy of Dermatology.
[97] K. Brown,et al. A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma , 2011, Nature.
[98] A. Weaver,et al. Malignant melanoma in solid transplant recipients: collection of database cases and comparison with surveillance, epidemiology, and end results data for outcome analysis. , 2011, Archives of dermatology.
[99] B. Cox,et al. A comparison of trends in melanoma mortality in New Zealand and Australia: the two countries with the highest melanoma incidence and mortality in the world , 2013, BMC Cancer.
[100] L. Tryggvadottir,et al. A melanoma epidemic in Iceland: possible influence of sunbed use. , 2010, American journal of epidemiology.
[101] T. Polascik,et al. Characteristics of patients diagnosed with both melanoma and renal cell cancer , 2013, Cancer Causes and Control.
[102] J R Eiser,et al. Is targeted early detection for melanoma feasible? Self assessments of risk and attitudes to screening , 2000, Journal of medical screening.
[103] E. Schernhammer,et al. Parkinson’s disease and cancer risk: a systematic review and meta-analysis , 2010, Cancer Causes & Control.
[104] A. Sivachenko,et al. A Landscape of Driver Mutations in Melanoma , 2012, Cell.
[105] Donald R. Miller,et al. Melanoma incidence and mortality among US whites, 1969-1999. , 2002, JAMA.
[106] A. Sober,et al. An estimate of the annual direct cost of treating cutaneous melanoma. , 1998, Journal of the American Academy of Dermatology.
[107] Jennifer L. Schwartz,et al. Thin primary cutaneous melanomas , 2002, Cancer.
[108] T. Fears,et al. Pediatric melanoma: risk factor and survival analysis of the surveillance, epidemiology and end results database. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[109] W. Clark,et al. High risk of malignant melanoma in melanoma-prone families with dysplastic nevi. , 1985, Annals of internal medicine.